Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability – considerations for drug development-Reference-Cited by-同舟云学术

Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability – considerations for drug development

Published:2012-04-18 Issue:6 Volume:8 Page:723-743
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Lai Yurong,Varma Manthena,Feng Bo,Stephens Joel Clay,Kimoto Emi,El-Kattan Ayman,Ichikawa Katsuomi,Kikkawa Hironori,Ono Chiho,Suzuki Akiyuki,Suzuki Misaki,Yamamoto Yuichi,Tremaine Larry

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425255.2012.678048

Reference129 articles.

1. Polymorphisms affecting gene regulation and mRNA processing: Broad implications for pharmacogenetics

2. A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity

3. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population

4. Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment

5. Membrane transporters in drug development

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of transporter assays for drug discovery and development: an update of the literature;Expert Opinion on Drug Discovery;2024-08-06

2. Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective;Clinical Pharmacokinetics;2024-06

3. Roles of breast cancer resistance protein and organic anion transporting polypeptide 2B1 in gastrointestinal toxicity induced by SN-38 under inflammatory conditions;Toxicology Letters;2024-04

4. Pharmacokinetics in Pharmacometabolomics: Towards Personalized Medication;Pharmaceuticals;2023-11-07

5. Genetic variation in organic cation transporters and considerations in drug development;Expert Opinion on Drug Metabolism & Toxicology;2023-03-04